STAY IN THE KNOW WITH HAEGARDA!

Sign up below to receive updates on the only C1-INH subcutaneous injection for the prevention of HAE attacks.

By submitting this form, you are consenting to receive email, direct mail, or text response with relevant information from CSL Behring. You may also receive relevant information from CSL Behring in the future. You will have the ability to opt out from receiving CSL Behring emails, mailings or text messages at any time. View our Privacy Policy here.

You are now leaving the current website.